Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 23, 2023 9:08 AM 1 min read

Apple, In A Cinema Near You Soon: Streaming Rivalry Heats Up As Apple To Splurge On Original Theatrical Releases

by Anusuya Lahiri Benzinga Editor
Follow
  • Apple Inc (NASDAQ:AAPL) eyes splurging $1 billion annually to produce movies likely for theatrical release to draw subscribers to its streaming service.
  • Apple has approached movie studios about partnering to release a few titles in theaters this year and a slate of more films in the future, Bloomberg reports.
  • The list of potential releases includes Martin Scorsese's Killers of the Flower Moon, which stars Leonardo DiCaprio; the spy thriller Argylle, from director Matthew Vaughn, and Napoleon, Ridley Scott's drama about the French conqueror.
  • Also Read: Netflixverse? Netflix Shows Interest In Building Franchise, Spends Extravagantly On Avenger Famed Directors For Latest Sci-Fi Project
  • The company has pledged to put movies in thousands of theaters for at least a month, in stark contrast to the exclusivity of its previous original film.
  • Apple TV+ will likely have 20 million - 40 million subscribers, fewer than rivals such as Netflix Inc (NASDAQ:NFLX) and Walt Disney Co (NYSE:DIS) Disney+.
  • Apple approached third-party distributors to manage the theatrical release, which entails substantial distribution fees and marketing budgets.
  • Paramount Global (NASDAQ:PARA) Paramount Pictures will release the Scorsese movie in theaters because the project originated at that studio and will collect a 10% distribution fee. 
  • Tech giants Apple and Amazon.com Inc (NASDAQ:AMZN) are boosting their investment in entertainment while cutting costs elsewhere.
  • Apple's plans will boost theater chains struggling to recover from the pandemic. The chains have repeatedly blamed studios' shortage of available films for their woes.
  • Contrastingly, the highest content spender Netflix wants its movies to appear in theaters and online simultaneously or within a couple of weeks.
  • Price Action: AAPL shares traded higher by 0.98% at $159.37 premarket on the last check Thursday.
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsTechMediaBriefs
AAPL Logo
AAPLApple Inc
$255.30-0.19%
Overview
AMZN Logo
AMZNAmazon.com Inc
$198.950.08%
DIS Logo
DISThe Walt Disney Co
$105.25-0.19%
NFLX Logo
NFLXNetflix Inc
$76.970.13%
AAPL Logo
AAPLApple Inc
$255.30-0.19%
Overview
AMZN Logo
AMZNAmazon.com Inc
$198.950.08%
DIS Logo
DISThe Walt Disney Co
$105.25-0.19%
NFLX Logo
NFLXNetflix Inc
$76.970.13%
Comments
Loading...